SCHEMBL20005793

SCHEMBL20005793

CCOc1cc(/C=C2\SC(=S)N(c3ccc(Cl)cc3)C2=O)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.68
KMT2A Q03164 11/20 0.68
MAPT P10636 7/20 0.68
POLB P06746 4/20 0.64
GAA P10253 3/20 0.64
FABP4 P15090 1/20 0.61
ALDH1A1 P00352 2/20 0.60
THRB P10828 2/20 0.60
RECQL P46063 2/20 0.60
NPC1 O15118 1/20 0.60
ALOX12 P18054 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
FAAH O00519 1/20 0.60
PTGES O14684 1/20 0.60
IDE P14735 1/20 0.60
MCL1 Q07820 1/20 0.60
HSPD1 P10809 1/20 0.59
HSPE1 P61604 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18103076 1.00 MEN1 (0.68) MEN1KMT2AMAPTPOLBGAA
SCHEMBL12726855 0.91 MEN1 (0.70) MEN1KMT2AMAPTPOLBGAA
SCHEMBL1421492 0.90 MEN1 (0.68) MEN1KMT2AMAPTPOLBGAA
SCHEMBL1421490 0.90 MEN1 (0.68) MEN1KMT2AMAPTPOLBGAA
SCHEMBL1421482 0.90 FAAH (0.73) MEN1KMT2AMAPTPOLBGAA
SCHEMBL1421478 0.90 FAAH (0.73) MEN1KMT2AMAPTPOLBGAA
SCHEMBL19999119 0.90 MEN1 (0.72) MEN1KMT2AMAPTPOLBGAA
SCHEMBL20005693 0.90 MEN1 (0.72) MEN1KMT2AMAPTPOLBGAA
SCHEMBL18103083 0.89 MEN1 (0.72) MEN1KMT2AMAPTPOLBGAA
SCHEMBL20005625 0.89 MEN1 (0.72) MEN1KMT2AMAPTPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885MAPT 3938/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885MAPT 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.